Cross-sectional study of the association between depressive symptoms and attentional bias to emotional stimuli in patients with acute stroke: Study protocol
Yamashita, M.; Takizawa, H.; Koizumi, K.; Hamaguchi, T.
Show abstract
Post-stroke depression affects approximately 30% of patients after stroke and is associated with delayed recovery in activities of daily living, reduced rehabilitation effectiveness, and poorer quality of life. Attentional bias modification may provide a low-burden, nonpharmacological approach for patients in the acute phase of stroke. However, before such an intervention can be implemented in clinical practice, it is necessary to clarify whether attentional bias is present in patients with acute stroke and depressive symptoms, whether cognitive function influences the manifestation of this bias, and which task and stimulus formats are most appropriate for assessment. This multicenter, cross-sectional observational study will enroll patients with acute stroke between 7-30 days after stroke onset. Depressive symptoms will be assessed using the depression subscale of the Hospital Anxiety and Depression Scale. Attentional bias will be measured under four task conditions based on the dot-probe task and the cue-target task, using face and word stimuli. Secondary assessments will include cognitive function, anxiety symptoms, activities of daily living, health-related quality of life, and clinical background variables. The aims of this study are to investigate the association between depressive symptoms and attentional bias in patients with acute stroke, compare attentional bias characteristics across task and stimulus types, and examine the potential influence of cognitive function on this association. The findings are expected to provide an empirical basis for designing future attentional bias modification protocols targeting post-stroke depression in the acute phase. This study has been registered with the UMIN Clinical Trials Registry (UMIN000059166).
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The whole day matters after stroke: Study protocol for a randomized controlled trial investigating the effect of a 'sit less, move more, sleep better program early after stroke 95%
- Protocol for Cerebellar Stimulation for Aphasia Rehabilitation (CeSAR): A randomized, double-blind, sham-controlled trial 94%
- Female Brain and Endocrinological Research – Veteran (FemBER-Vet) Study: A study protocol for identifying endocrinological, lifestyle and psychosocial determinants of brain health outcomes in female veterans for future intervention success 94%
Similar papers in this journal
- The Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study 94%
- Optimising activity and diet compositions for dementia prevention: Protocol for the ACTIVate prospective longitudinal cohort study 94%
- The New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol 93%
Similar papers in this journal
- Boston Cognitive Assessment (BOCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance 93%
- PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 91%
- Efficacy and safety of tirofiban following intravenous thrombolysis: A systematic review and meta-analysis of randomized controlled trials 91%
Similar papers in this journal
- Impaired everyday executive functions and cognitive strategy use on the Weekly Calendar Planning Activity in individuals with stroke undergoing acute inpatient rehabilitation 95%
- Motivational Strategies for Stroke Rehabilitation: A Descriptive Cross-sectional Study 95%
- Rasch validation of a new scale to measure dependency in arm use in daily life: the Upper Limb Lucerne ICF-based Multidisciplinary Observation Scale (UL-LIMOS) 94%
Similar papers in this journal
- The Helping Older People Engage (HOPE) Study: Protocol & COVID Modifications for a Randomized Trial 91%
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial 90%
- A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.